reported that AFP of > 1000 ng/mL is a significant risk for HCC recurrence and suggested that patients with AFP of > 1000 ng/mL should be excluded from OLT in the Milan criteria (16). The gene discussed is AFP; the disease is hepatocellular carcinoma.